Travellers Vaccinated With Covaxin Can Enter US From November 8
Mumbai: Travellers fully vaccinated with Covaxin can enter the US from November 8. The Centers for Disease Control acknowledged the WHO approval for Emergency Use Listing to Covaxin.
“CDC’s travel guidance applies to FDA approved or authorized and WHO Emergency Use Listing vaccines and encompasses any new vaccines that may be added to either of those lists over time,” US Centers for Disease Control (CDC) press officer Scott Pauley told news agency ANI.
The CDC on Wednesday accepted the WHO’s grant of an Emergency Use List (EUL) for India’s indigenous vaccine, developed by Bharat Biotech
“WHO has granted emergency use listing (EUL) to #COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19,” the global health body said in a tweet.
The approval, after a long wait, would allow for greater recognition of Covaxin by other countries, which would allow Indian travellers to qualify for the exemptions that countries offer to people who are vaccinated.
According to the WHO, Covaxin has a 78 per cent efficacy rate against Covid-19 and is “highly suitable” for low- and middle-income countries because it is easy to store.
The vaccine was co-developed by the Indian Council of Medical Research (ICMR), which comes under the Union health ministry.
The new US travel rules will also accept travellers fully vaccinated with Pfizer-BioNTech, Johnson & Johnson, Moderna, Oxford-AstraZeneca, Covishield, Sinopharm and Sinovac.
Follow us on Twitter, Instagram, and like us on Facebook for the latest updates and interesting stories.
